Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-14 Sale | 2023-09-18 7:03 pm | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 8,641 | $2.1017 | $18,161 | 2,403,882 (Direct) | View |
| 2023-09-11 Sale | 2023-09-13 8:16 pm | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 27,917 | $2.2675 | $63,301 | 2,412,523 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-26 Option Award | 2024-03-28 4:33 pm | N/A 2034-03-26 | Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer | 1,071,242 | $3.83 | 1,071,242 (Direct) | View |
| 2023-09-13 Tax Withholding | 2023-09-13 8:16 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 184,742 | $2.13 | 2,412,523 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 5:00 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 469,483 | $0 | 2,625,182 (Direct) | View |
| 2023-03-24 Disposition | 2023-03-28 4:48 pm | N/A 2031-03-30 | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 1,052,286 | $0 | 3,207,985 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:48 pm | N/A 2031-03-30 | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 1,755,665 | $0 | 3,207,985 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-03 7:39 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer | 95,684 | $0 | 1,452,320 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-15 7:56 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer | 315,273 | $0 | 1,356,636 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer | 742,574 | $0 | 1,041,363 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer | 962,289 | $0 | 962,289 (Direct) | View |
Ownership | 2021-10-07 9:28 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer | 0 | $0 | 1,351,075 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 4:17 pm | 2020-06-06 2029-06-06 | REXAHN PHARMACEUTICALS INC. | RNN | Sullivan Lara Director | 3,537 | $0 | 3,537 (Direct) | View |